Patents by Inventor Ismail Mohammed

Ismail Mohammed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911620
    Abstract: Disclosed are devices, systems and methods for non-invasive neuromodulation system for prompt treatment of cerebral and/or ocular strokes caused by acute dysregulated reduced cerebral blood flow (CBF) and/or ocular blood flow (OBF) by up regulation of trigemino-vascular system (TVS), and trigeminal autonomic brain reflexes (TABRs) through stimulation of ophthalmic nerve. Additionally or alternatively, the subject's sympathetic nervous system (SNS) is down regulated centrally by intravenous administration of pharmacological dose of ascorbic acid. The site of stimulation of ophthalmic nerve includes but not limited to nasal vestibule, nasal bridge, and forehead and upper eyelid. In some embodiments, the devices are handheld, portable with nose supported, having one or more intra-nasal or extra-nasal application heads. The signal can include vibration, chemical, ultrasonic, optical, electrical, hybrid electro-optical or combination of two or more of these types of stimuli.
    Type: Grant
    Filed: July 19, 2020
    Date of Patent: February 27, 2024
    Inventor: Ismail Mohammed Yousif Musallam
  • Publication number: 20210023372
    Abstract: Disclosed are devices, systems and methods for non-invasive neuromodulation system for prompt treatment of cerebral and/or ocular strokes caused by acute dysregulated reduced cerebral blood flow (CBF) and/or ocular blood flow (OBF) by up regulation of trigemino-vascular system (TVS), and trigeminal autonomic brain reflexes (TABRs) through stimulation of ophthalmic nerve. Additionally or alternatively, the subject's sympathetic nervous system (SNS) is down regulated centrally by intravenous administration of pharmacological dose of ascorbic acid. The site of stimulation of ophthalmic nerve includes but not limited to nasal vestibule, nasal bridge, and forehead and upper eyelid. In some embodiments, the devices are handheld, portable with nose supported, having one or more intra-nasal or extra-nasal application heads. The signal can include vibration, chemical, ultrasonic, optical, electrical, hybrid electro-optical or combination of two or more of these types of stimuli.
    Type: Application
    Filed: July 19, 2020
    Publication date: January 28, 2021
    Inventor: Ismail Mohammed Yousif Musallam
  • Publication number: 20210022948
    Abstract: Disclosed are devices, systems and methods for non-invasive neuromodulation system for treating inherited or acquired retinal, choroidal and optic nerve disorders caused by acute or chronic dysregulated reduced ocular blood flow (OBF) and/or energy failure by up regulation of trigemino-vascular system (TVS), trigeminal autonomic brain reflexes (TABRs) and pancreatic trigemino-vagal reflex (TVR) through stimulation of ophthalmic nerve (V1), more specifically but not limited to SP, and CGRP containing unmyelinated C nerve fibers. The invention, in some embodiments thereof, relates to the methods for enhancing SP and CGRP expression in neurovascular tissue of the retina and choroid.
    Type: Application
    Filed: July 19, 2020
    Publication date: January 28, 2021
    Inventor: Ismail Mohammed Yousif Musallam
  • Patent number: 8895611
    Abstract: The cytotoxic compounds are gold(III) complexes of the type [(diaminocyclohexane)AuCl2]Cl, derived from sodium tetrachloroaurate(III) dihydrate NaAuCl4.2H2O. Specifically, the cytotoxic compounds are gold complexes of isomers of 1,2-diaminocyclohexane, namely cis-(±)-1,2-(diaminocyclohexane)AuCl3, trans-(±)-1,2-(diaminocyclohexane)AuCl3 and S,S-(+)-1,2-(diaminocyclohexane)AuCl3. In order to treat cancer cells in a patient, such as human prostate cancer cells or human gastric cancer cells, an effective amount of the isomer of 1,2-(diaminocyclohexane)AuCl3 is administered to the cancer cells in the patient. The isomer of 1,2-(diaminocyclohexane)AuCl3 is preferably administered with a concentration ranging between about 10 ?M and 20 ?M.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: November 25, 2014
    Assignees: King Fahd University of Petroleum and Minerals, King Abdulaziz City for Science and Technology
    Inventors: Anvarhusein Abdulkadir Isab, Mohammed Ismail Mohammed Wazeer, Said Salman Al-Jaroudi, Saleh Abdulaziz Altuwaijri
  • Patent number: 7588285
    Abstract: A cargo box for a pickup truck having a header panel with integral welding braces or struts. The cargo box has left and right sidewalls defining the left and right sides of the cargo box, respectively, a tailgate attached to the rear end of at least one of the left and right sidewalls, a cargo box floor spanning the left and right sidewalls, and a header panel having a main body spanning the front ends of the left and right sidewalls to form a front side of the cargo box. The header panel has integral left and right lateral sides extending from and integral with its main body and these are welded directly to the left and right sidewalls without any intervening brace above the level of the cargo bed floor. Left and right braces are welded to the lower end of the header panel and the left and right sidewalls at and below the cargo bed floor, so that a majority of the mass of the brace is below the lower edge of the header panel.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: September 15, 2009
    Assignee: Nissan Technical Center North America, Inc.
    Inventor: Ismail Mohammed
  • Publication number: 20090079230
    Abstract: A cargo box for a pickup truck having a header panel with integral welding braces or struts. The cargo box has left and right sidewalls defining the left and right sides of the cargo box, respectively, a tailgate attached to the rear end of at least one of the left and right sidewalls, a cargo box floor spanning the left and right sidewalls, and a header panel having a main body spanning the front ends of the left and right sidewalls to form a front side of the cargo box. The header panel has integral left and right lateral sides extending from and integral with its main body and these are welded directly to the left and right sidewalls without any intervening brace above the level of the cargo bed floor, Left and right braces are welded to the lower end of the header panel and the left and right sidewalls at and below the cargo bed floor, so that a majority of the mass of the brace is below the lower edge of the header panel.
    Type: Application
    Filed: September 24, 2007
    Publication date: March 26, 2009
    Applicant: NISSAN TECHNICAL CENTER NORTH AMERICA, INC.
    Inventor: Ismail Mohammed